Skip to main content

Hospital Readmission Reduction Program (HRRP) Revisited: Outcomes, Risks & Benefits

No Ratings

**Presented at the 2022 CMSA Annual Conference**
*** RN, CCM and SW credits ***

There has been a focus on readmission reduction and prevention in acute care facilities since 2009. Potentially preventable readmissions have been related to failed or ineffective discharge planning especially for patients with chronic, high-focus diseases such as congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD). With over 10 years of work invested into the Hospital Readmission Reduction Program, it is an excellent opportunity to review the outcomes, risks and benefits identified through the myriad of literature and evidence-based practices related to readmission reduction activities. This presentation will explore the history of the HRRP, current practices to reduce readmissions and explore the risks and benefits to patients and the healthcare system.


  1. Identify key events in the history of the Hospital Readmission Reduction Program (HRRP) and reasons for focus on readmissions.
  2. Define readmission reduction outcomes and evidence-based practices surrounding readmissions from 2009-current.
  3. Analyze topics and concepts associated with the risks and benefits identified in the literature related to HRRP initiatives.